Search
for
Sort by
Research 241–270 of 1000+
- Provenge is Talk of GU Malignancies Congress
- Diseases of the Canine Prostate Gland
- 'The Cry of the Children': The Edwardian Medical Campaign Against Maternal Drinking
- Anthracycline analogs The past, present, and future
- Alcoholic Extract of <i>Eclipta alba</i> Shows <i>In Vitro</i> Antioxidant and Anticancer Activity without Exhibiting Toxicological Effects
- Atroposelective Synthesis of Biaryl <i>N</i>‐Oxides via Cu‐Catalyzed De Novo Heteroaromatic <i>N</i>‐Oxide Ring Formation
- Management of Toxicities of Targeted Therapies
- Clinical Guidance on the Monitoring and Management of Trastuzumab Deruxtecan (T-DXd)-Related Adverse Events: Insights from an Asia-Pacific Multidisciplinary Panel
- Sacituzumab Govitecan-Hziy (Trodelvy™)
- Rare Case of Alopecia: Alopecia Neoplastica
- Sinergitas Efek Kombinasi Ekstrak Daun SirsaK (Annona muricata Linn) Dengan Doksorubisin Pada Sel Kanker Payudara MCF-7
- Molecular mechanisms of asymmetric divisions in mammary stem cells
- Hypertrichosis lanuginosa acquisita following cytotoxic chemotherapy
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Self-Assembled Berberine-Sinapic Acid Nanomedicine for Synergistic Chemotherapy
- Quiescent Tissue Stem Cells Evade Immune Surveillance
- Atlas of Geriatric Dermatology
- Mini Review on Polycystic Ovary Syndrome (PCOS)
- WNT10B (wingless-type MMTV integration site family)
- Roles of Wnt7a in embryo development, tissue homeostasis, and human diseases
- Management of Dermatologic Toxicities
- A medicinal and edible formula YH0618 ameliorates the toxicity induced by Doxorubicin via regulating the expression of Bax/Bcl-2 and FOXO4
- EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines
- An Elevated Tumor Marker and Adrenarche in a Child Using Lavender Oil
- Metformin and Malignant Tumors: Not Over the Hill
- Protein Kinase C as a Therapeutic Target
- Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930
- Keeping Our Eye on the Ball: The American Society of Preventive Oncology in 2009
- Antibody Drug Conjugates
- Ca <sup>2+</sup> -mediated protein citrullination regulates proliferation in the regenerating and malignant CNS